Login To See Content

To see additional content on this page, you must be logged in. If you don't have a login yet, click here to open the registration form.
Resources > Non-clinical resources >

Advice, Tips, Pitfalls

 ARISE logo

Social Media in Clinical Trials:

The Arise Study

 Rinaldo Bellomo



The benefits of social tools such as Twitter and Facebook are now being employed by the research community to increase awareness and hopefully improve recruitment into clinical trials.

An example of this is the ARISE study, an ongoing multicentre randomized control trial of early goal-directed therapy in patients presenting to the Emergency Department in Australia.

They now have a Facebook page and a Twitter feed giving updates on what's happening with he trial and allowing interaction with the investigators running the trial, which offers a rare opportunity to ask any questions you've got and to get the answers from the horses' mouth.

So if you're interested and want to support research initiatives you can follow ARISE on Twitter here and their Facebook page here.


The use of intention-to-treat analysis has come up at a couple of recent journal clubs, bandied about as if to suggest that the outcomes and conclusions were unassailable. However, ITT analysis may not be quite the bullet proof cladding as it iseems to be made out. So I've trotted off to prove to myself that I really did understand the concept and it turns out I almost did. So, courtesy of the Medical Journal of Australia, the Cochrane Collaboration open learning materail resource and Wikipedia (the occasional pinch of salt may be required), here's a quick summary of intention to treat analysis:

Our Sponsors
ICN Home
Follow us on Twitter
Follow Us on Facebook
Subscribe to the ICN RSS feed